Finance

Beta
Lists
4892:TYO
Cyfuse Biomedical KK
¥590.00
+1.55%
(+9.00) 1D
May 29, 3:30:00 PM GMT+9  ·   JPY
All symbols
SymbolPriceChange% Change
Generating top insights for 4892...
Open
¥584
High
¥608
Low
¥584
Mkt. cap
5.95B
Avg. vol.
140.77K
Volume
43.80K
52-wk high
¥967
52-wk low
¥516
EPS
-¥90
No. of employees
23
Open
¥584
High
¥608
Low
¥584
Mkt. cap
5.95B
Avg. vol.
140.77K
Volume
43.80K
52-wk high
¥967
52-wk low
¥516
EPS
-¥90
No. of employees
23
News stories
From sources across the web
About Cyfuse Biomedical KK
CEO-
Employees23
FoundedAug 11, 2010
Headquarters-
SectorHealth care
Previous reportsAll values in JPY
Loading Previous Earnings...
Income statement
Revenue
Net income
All values in JPY
Jun 2025
Sep 2025
Dec 2025
Mar 2026
Revenue
5.00M
32.00M
169.00M
28.00M
Cost of goods sold
5.00M
21.00M
81.00M
8.00M
Cost of revenue
5.00M
21.00M
81.00M
8.00M
Research and development expenses
-
-
416.00M
-
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
231.00M
230.00M
-203.00M
236.00M
Operating expense
231.00M
230.00M
227.00M
236.00M
Total operating expenses
236.00M
251.00M
308.00M
244.00M
Operating income
-231.00M
-219.00M
-139.00M
-216.00M
Other non operating income
-7.00M
-14.00M
20.00M
-3.00M
EBT including unusual items
-239.00M
-235.00M
-125.00M
-224.00M
EBT excluding unusual items
-239.00M
-235.00M
-125.00M
-224.00M
Income tax expense
1.00M
-
1.00M
-
Effective tax rate
-0.42%
-
-0.80%
-
Other operating expenses
-
-
-
-
Net income
-240.00M
-235.00M
-126.00M
-224.00M
Net profit margin
-4,800.00%
-734.38%
-74.56%
-800.00%
Earnings per share
-
-
-
-
Interest and investment income
1.00M
2.00M
-
1.00M
Interest expense
-2.00M
-4.00M
-6.00M
-6.00M
Net interest expenses
-1.00M
-2.00M
-6.00M
-5.00M
Depreciation and amortization charges
-
-
14.00M
-
EBITDA
-222.50M
-209.50M
-129.75M
-206.75M
Gain or loss from assets sale
-
-
-
-
AI content may include mistakes. Learn more

Research

AI content may include mistakes. Learn more